Xunlei Ltd: Form 20-F for the period ended Dec 31, 2019
Filed with the SEC on Apr 28, 2020 and accepted by EDGAR at Apr 28, 2020, 16:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $180.7m | us-gaap:Revenues |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $99.9m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $80.8m | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $68.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | −$56.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | −$53.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 337,845,675 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | −$45.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $3.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-12-31 | $162.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $316.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $424.7m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $111.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $129.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-12-31 | $296.9m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-12-31 | 336,522,780 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-20-052375. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.